142 related articles for article (PubMed ID: 12408341)
1. Prognostic implication of nm23-H1 expression in colorectal carcinomas.
Dursun A; Akyürek N; Günel N; Yamaç D
Pathology; 2002 Oct; 34(5):427-32. PubMed ID: 12408341
[TBL] [Abstract][Full Text] [Related]
2. nm23 protein expression in colorectal carcinoma metastasis in regional lymph nodes and the liver.
Sarris M; Lee CS
Eur J Surg Oncol; 2001 Mar; 27(2):170-4. PubMed ID: 11289754
[TBL] [Abstract][Full Text] [Related]
3. NM23-H1 immunostaining is inversely associated with tumour staging but not overall survival or disease recurrence in colorectal carcinomas.
Cheah PY; Cao X; Eu KW; Seow-Choen F
Br J Cancer; 1998 Apr; 77(7):1164-8. PubMed ID: 9569056
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of the loss of heterozygosity of Nm23-H1 and p53 genes in human colorectal carcinomas.
Campo E; Miquel R; Jares P; Bosch F; Juan M; Leone A; Vives J; Cardesa A; Yague J
Cancer; 1994 Jun; 73(12):2913-21. PubMed ID: 8199988
[TBL] [Abstract][Full Text] [Related]
5. Expression of nm23-H1 predicts lymph node involvement in colorectal carcinoma.
Tannapfel A; Köckerling F; Katalinic A; Wittekind C
Dis Colon Rectum; 1995 Jun; 38(6):651-4. PubMed ID: 7774480
[TBL] [Abstract][Full Text] [Related]
6. nm23-H1 protein immunoreactivity in cancers of the gallbladder, extrahepatic bile ducts and ampulla of Vater.
Lee CS; Pirdas-Zivcic A
Pathology; 1994 Oct; 26(4):448-52. PubMed ID: 7892048
[TBL] [Abstract][Full Text] [Related]
7. nm23-H1 immunoreactivity as a prognostic factor in differentiated thyroid carcinoma.
Zafon C; Obiols G; Castellví J; Tallada N; Galofré P; Gemar E; Mesa J; Simó R
J Clin Endocrinol Metab; 2001 Aug; 86(8):3975-80. PubMed ID: 11502841
[TBL] [Abstract][Full Text] [Related]
8. Expression of nm23-H1 in colorectal cancer: no association with metastases, histological stage, or survival.
Tabuchi Y; Nakamura T; Kuniyasu T; Ohno M; Nakae S
Surg Today; 1999; 29(2):116-20. PubMed ID: 10030735
[TBL] [Abstract][Full Text] [Related]
9. High frequency of concomitant nm23-H1 and E-cadherin transcriptional inactivation in primary non-inheriting colorectal carcinomas.
Garinis GA; Manolis EN; Spanakis NE; Patrinos GP; Peros G; Menounos PG
J Mol Med (Berl); 2003 Apr; 81(4):256-63. PubMed ID: 12684753
[TBL] [Abstract][Full Text] [Related]
10. Elevated nm23 protein expression is correlated with diminished progression-free survival in patients with epithelial ovarian carcinoma.
Srivatsa PJ; Cliby WA; Keeney GL; Dodson MK; Suman VJ; Roche PC; Podratz KC
Gynecol Oncol; 1996 Mar; 60(3):363-72. PubMed ID: 8774640
[TBL] [Abstract][Full Text] [Related]
11. nm23-H1 protein immunoreactivity in laryngeal carcinoma.
Lee CS; Redshaw A; Boag G
Cancer; 1996 Jun; 77(11):2246-50. PubMed ID: 8635091
[TBL] [Abstract][Full Text] [Related]
12. [The expression of nm23-H1 genes with clinical prognosis in endometrial carcinoma].
Guo C; Wei L; Fu Q
Zhonghua Fu Chan Ke Za Zhi; 1999 Jul; 34(7):423-5. PubMed ID: 11360656
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of nm23-H1 and nm23-H2 genes in colorectal carcinomas and loss of nm23-H1 expression in advanced tumour stages.
Martinez JA; Prevot S; Nordlinger B; Nguyen TM; Lacarriere Y; Munier A; Lascu I; Vaillant JC; Capeau J; Lacombe ML
Gut; 1995 Nov; 37(5):712-20. PubMed ID: 8549951
[TBL] [Abstract][Full Text] [Related]
14. The prediction of lymph node metastases in colorectal cancer by expression of the nucleoside diphosphate kinase/nm23-H1 and histopathological variables.
Tannapfel A; Katalinic A; Köckerling F; Wittekind C
Am J Gastroenterol; 1997 Jul; 92(7):1182-6. PubMed ID: 9219795
[TBL] [Abstract][Full Text] [Related]
15. Analysis of both NM23-h1 and NM23-H2 expression identifies "at-risk" patients with colorectal cancer.
Brenner AS; Thebo JS; Senagore AJ; Duepree HJ; Gramlich T; Ormsby A; Lavery IC; Fazio VW
Am Surg; 2003 Mar; 69(3):203-8; discussion 208. PubMed ID: 12678475
[TBL] [Abstract][Full Text] [Related]
16. High level of Nm23-H1 gene expression is associated with local colorectal cancer progression not with metastases.
Zeng ZS; Hsu S; Zhang ZF; Cohen AM; Enker WE; Turnbull AA; Guillem JG
Br J Cancer; 1994 Nov; 70(5):1025-30. PubMed ID: 7947079
[TBL] [Abstract][Full Text] [Related]
17. NM-23 H1 immunohistochemistry is not useful as predictor of metastatic potential of colorectal cancer.
Lindmark G
Br J Cancer; 1996 Nov; 74(9):1413-8. PubMed ID: 8912537
[TBL] [Abstract][Full Text] [Related]
18. Expression of nm23 in gastric carcinoma: association with tumor progression and poor prognosis.
Müller W; Schneiders A; Hommel G; Gabbert HE
Cancer; 1998 Dec; 83(12):2481-7. PubMed ID: 9874452
[TBL] [Abstract][Full Text] [Related]
19. Inverse association of nm23-H1 expression by colorectal cancer with liver metastasis.
Yamaguchi A; Urano T; Fushida S; Furukawa K; Nishimura G; Yonemura Y; Miyazaki I; Nakagawara G; Shiku H
Br J Cancer; 1993 Nov; 68(5):1020-4. PubMed ID: 8217591
[TBL] [Abstract][Full Text] [Related]
20. The significance of nm23 protein expression in human gastric carcinomas.
Ura H; Denno R; Hirata K
Surg Today; 1996; 26(12):957-65. PubMed ID: 9017955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
